A Prediction Model in Pregnant Women With Aplastic Anemia
NCT ID: NCT07101770
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2025-11-27
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Iron Metabolism Parameters At First Trimester and preGnancy outcomE
NCT03176147
Identification of Early Predictors of Fetomaternal Hemorrhage
NCT01232387
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282
Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium
NCT06527807
Clinical Features, Outcomes, and Therapeutics of Pregnancy-Related Aortic Dissection
NCT05501145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Currently, most cohort studies on pregnant women with AA in China are retrospective, single-center studies with small sample sizes, resulting in insufficient data and a lack of multicenter, prospective cohort studies.
This study is a multicenter, retrospective and prospective observational study that will enroll pregnant women with aplastic anemia. It will collect baseline patient information and diagnostic data, conduct regular prospective follow-ups via questionnaires, telephone interviews, video consultations, online platforms, and in-person visits, and record treatment regimens, comorbidities, and prognostic outcomes. The study aims to provide comprehensive data on the epidemiology and clinical outcomes of pregnant women with aplastic anemia in China, and aimed to develop and validate a predictive model for adverse pregnancy outcomes in pregnant women with AA, with the goal of guiding early clinical decision-making and improving their overall health outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with adverse pregnancy outcomes
A combined retrospective and prospective observational follow-up
A combined retrospective and prospective observational follow-up
without adverse pregnancy outcomes
A combined retrospective and prospective observational follow-up
A combined retrospective and prospective observational follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A combined retrospective and prospective observational follow-up
A combined retrospective and prospective observational follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. pregnant women with newly diagnosed aplastic anemia during pregnancy
Exclusion Criteria
2. without coagulation series results
3. termination of pregnancy before 20 weeks of gestation
4. multiple pregnancy
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tianjin Medical University General Hospital
OTHER
Lanzhou University Second Hospital
OTHER
The Affiliated Hospital of Inner Mongolia Medical University
OTHER
General Hospital of Ningxia Medical University
OTHER
Peking Union Medical College Hospital
OTHER
Peking University Third Hospital
OTHER
The First Affiliated Hospital of Anhui Medical University
OTHER
Wuhan TongJi Hospital
OTHER
Peking University First Hospital
OTHER
Chinese PLA General Hospital
OTHER
Second Xiangya Hospital of Central South University
OTHER
The First Affiliated Hospital of Soochow University
OTHER
Qilu Hospital of Shandong University
OTHER
Shanxi Provincial People's Hospital
OTHER_GOV
The First Affiliated Hospital of Zhengzhou University
OTHER
Shandong Provincial Hospital
OTHER_GOV
Shanxi Bethune Hospital
OTHER
Yantai Yuhuangding Hospital
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
The Third Affiliated Hospital of Guangzhou Medical University
OTHER
First Affiliated Hospital of Zhejiang University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Peking University People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiao Hui Zhang
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaohui Zhang, MD
Role: PRINCIPAL_INVESTIGATOR
Peking University People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University People's Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025PHB251-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.